ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMYT Amryt Pharma Plc

143.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 143.00 151.00 170.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Amryt Pharma Share Discussion Threads

Showing 251 to 269 of 7375 messages
Chat Pages: Latest  19  18  17  16  15  14  13  12  11  10  9  8  Older
DateSubjectAuthorDiscuss
16/6/2016
16:06
Looks to me that it could go lower than 16p in the short term. Good future prospects for AMYT, but I can't see the share doing anything in the short term. General Mkt conditions not good and good news not likely until 2017.
papillon
16/6/2016
15:22
16p vs the reverse takeover share price looks like an opportunity to me, assuming things unfold in the future as per the general Business Plan
pottermagic2310
16/6/2016
14:59
It's knocking all of mine :-(
bigwavedave
16/6/2016
14:03
EU vote knocking most of my shares
currypasty
16/6/2016
13:37
Well, this is looking miserable again.
For those of us who hold, I guess it'll just have to be a case of waiting for the Summer/Autumn newsflow.

bigwavedave
13/6/2016
11:19
Proactive interview:
flyingswan
13/6/2016
10:52
Amryt Pharma chief looking to “unlock a large market opportunity”
bigwavedave
10/6/2016
11:05
They won't let me post the link. But it's at proactive investors website under Beaufort Securities Breakfast Alert.
bigwavedave
10/6/2016
11:03
Beaufort Securities: "Furthermore, as soon as the Amryt phase three trial of Episalvan for Epidermolysis Bullosa gets under way then Amryt is going to be of even more interest to these multinational pharmaceutical companies. In view of the potential sales for Orphan drugs, and the interest from Big Pharma, we recommend as a Speculative Buy."

[...]

bigwavedave
10/6/2016
08:53
I certainly don't read too much into these Results.
They're far too reflective of the failing/failed FASTNET O&G/EQUITY Businesses and nothing much to do with the new Company we're now invested in.
The Report had to be produced and is very reflective of that legacy situation.
I'm far more interested in the current Business Plan for this new Business and some sort of realistic Forecast for the next 18-24 months.

pottermagic2310
10/6/2016
08:32
results were pre reverse takeover, ended December.

still has £10m cash

currypasty
09/6/2016
17:42
Seems like the Amyt catch word is, loss, as it is prevalent throughout the account RNS.
jacksonpollack
09/6/2016
14:39
Did anyone listen in on the conf call? I was away. Nothing on the link now. I assume no revelations.
bigwavedave
09/6/2016
07:44
one day ill be in profit on those old fast shares
currypasty
09/6/2016
07:42
Keep buying Currypasty . You know you want to .
talkman2
09/6/2016
07:33
Another addition to the management team from Shire, Michele Belindi
alphabravo321
08/6/2016
13:57
Too late. Back to conventional pricing!
Hopefully we'll get some good new news tomorrow.

bigwavedave
08/6/2016
12:57
bargain, get 10 million, then sell straight away
currypasty
08/6/2016
12:08
On TDDirect, I can sell these for 18.7751 or buy them for 18.7p. Very odd.
bigwavedave
Chat Pages: Latest  19  18  17  16  15  14  13  12  11  10  9  8  Older

Your Recent History

Delayed Upgrade Clock